# Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients

> **NCT02655770** · PHASE4 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 40 (actual)

## Conditions studied

- Diabetes Mellitus Type 2
- Diastolic Dysfunction
- Cardiac MRI
- Myocardial Perfusion

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02655770
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-01-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02655770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02655770, "Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02655770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*